Abstract
Objective :Acute Leukemia is rare in infants. It is characterized by non-specific symptomatology requiring a high index of suspicion on the part of a pediatrician for referral and diagnosis. It has peculiar biological features, unresponsiveness to treatment and poor prognosis.Methods: Eighteen infants with acute leukemia were seen during 1994 to 2001 and were analyzed on the basis of clinical and laboratory data. There were 13 cases of Acute Lymphoblastic Leukemia (ALL), 4 cases of Acute Myeloid Leukemia (AML) and one case remained unclassifiable, as the surface markers could not be done. Morphologically 9/13 cases of ALL were of FAB L1 type and remaining of L2 subtype, and 2/4 cases of AML were of FAB M1 type and remaining of M2 subtype.Result: Clinical data was available completely only in 11 cases. Hyperleucocytosis was present in 4 cases, organomegaly in 8 cases and lympadenopathy in 5 cases. One patient presented with a chloroma in the retrorbital region although there was no parenchymal involvement of the brain. Immunophenotyping could be done in 13 cases, where 7 cases were diagnosed as CALLA positive-ALL (HLADR+, CD19+, CD10+), 2 cases as Early Pre-B ALL (HLADR+, CD19+, CD10 negative), one as TALL (cCD3+, CD2+, CD7+) and 3 cases as AML (CD13+, CD33+, HLADR+). None of our patients received treatment.
Similar content being viewed by others
References
Chopra HK, Barbhaya SA, Badrinath Yet al. Infantile Leukemia.J Hematol Blood Transi 1994; 12:39–45.
Mcarmen Fernandez, Brain Weiss, Susan Atwater, Kevin Shannon, Katherine K Matthay. Congenital Leukemia: Successful Treatment of a Newborn with t(5;ll)(q31;q23).J Pediatr Hemat/Oncol 1999; 21(2): 152–157.
Pui C, Kalwinsky DK, Schell MJ, Mason CA, Mirro J Jr, Dahl GV. Acute nonlymphoblastic leukemia in infants: Clinical presentation and outcome.J Clin Oncol 1988; 6:1008–1013.
Crist W, Pullen J, Boyett Jet al. Clinical and biological features predict a poor prognosis in acute lymphoblastic leukemias in infants. A Pediatric Oncology Group Study.Blood 1986; 67: 135–140.
Reaman G, Zeltzer P, Bleyer WA, Amendola B, Level C, Sather Het al. Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children’s Cancer Study Group.J Clin Oncol 1985; 3:1513–1521.
ChessellsJM, Eden OB, Bailey CC Lilleyman JS, Richards SM. Acute lymphoblastic leukemia in infancy: experience in MRC UKALL trials: report from the Medical Research Council Working party on Childhood Leukemia.Leukemia 1994; 8: 1275–1279.
Ferster A, Bertrand Y, Benoit Y, Boilletot A, Behar C, Margueritte Get al. Improved survival for acute lymphoblastic leukemia in infancy: the experience of EORTC-Childhood Leukemia Cooperative Group.Br J Haematol 1994; 86:284–290.
Hayhoe FGH, Quanglino D, DollR. The cytology and cytochemistry of acute leukemias.London Churchill Livingstone 1980.
Kamat DM, Gopal R, Advani SHet al. Pattern of subtypes of acute lymphoblastic leukemia in India.Leuk Res 1985; 9: 927–934.
Boindi A, Cimino G, Pieters R, Pui C. Biological and therapeutic aspects of infant leukemia.Blood 2000; 96 (1): 24–33.
Greaves MF. Infant leukemia biology, aetiology and treatment.Leukemia 1996; 10: 372–377.
Birch JM, Blair V. The epidemiology of infant cancers.Br J Cancer (Suppl) 1992; 18: S2-S4.
Ludwig WD, Bartram CR, Harboltet al. Phenotype and genotypic heterogeneity in infant acute leukemia.Leukemia 1989; 3:431–439.
Mirro J Zipi TF, Pui Cet al. Acute mixed lineage leukemia Clinicopathologic correlations and prognostic significance.Blood 1985; 66:1115–1123.
Ferster A, Bertrand Y, Benoit Yet al. Improved survival for acute lymphoblastic leukemia in infancy: the experience of EORTC-Childhood Leukemia Cooperative Group.Br J Haematol 1994; 86: 284–290.
Rubnitz JE, Link MP, Shuster JJet al. Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemi: a Pediatric Oncology Group Study:Blood 1994; 2: 570–573.
Pui CH, Evans WE. Acute lymphoblastic leukemia.N Engl J Med 1998; 339: 605–615.
Reaman GH, Sposto R, Sensel MGet al. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children’s Cancer Group.J Clin Oncol 1999; 17:445–455.
Dreyer ZE, Steuber CP, Bowman WPet al. High risk infant ALL and improved survival with intensive chemotherapy.Proc Am Soc Clin Oncol. 1998; 17:529a.